共 21 个 OTC 专论产品
| 序号 | NDC编码 | 商品名 | 剂型 | 上市日期 | 专论编号 |
|---|---|---|---|---|---|
| 1 | 51316-654-01 | Acne Treatment Cream | CREAM | 2026-08-03 | M006 |
| 2 | 51316-893-01 | Acne Control Cleanser | LIQUID | 2026-07-01 | M006 |
| 3 | 51316-972-01 | Acne Spot Treatment Cream | CREAM | 2026-08-03 | M006 |
| 4 | 69842-571-02 | CVS Health Acne Control Cleanser Acne Medication | LOTION | 2014-01-01 | M006 |
| 5 | 69842-583-01 | CVS Clarifying Body Wash Acne Treatment | LOTION | 2014-01-01 | M006 |
| 6 | 69842-312-30 | No Drip Nasal Mist | LIQUID | 2018-08-30 | M012 |
| 7 | 69842-315-30 | No Drip Severe Nasal Mist | LIQUID | 2018-08-30 | M012 |
| 8 | 69842-316-51 | Maximum Strength Nasal Decongestant | LIQUID | 2018-08-30 | M012 |
| 9 | 69842-725-47 | CVS Health Advanced Scar Gel | GEL | 2019-05-22 | M016 |
| 10 | 69842-388-01 | CVS Eczema Relief Skin Protectant | CREAM | 2014-01-01 | M016 |
| 11 | 51316-860-01 | Eczema Skin Relief Cream | CREAM | 2026-04-13 | M016 |
| 12 | 69842-485-08 | CVS Maximum Strength Anti-Itch Cream | CREAM | 2022-04-06 | M016 |
| 13 | 51316-399-01 | CVS Health Vitamin A and D Skin Protectant | OINTMENT | 2010-04-29 | M016 |
| 14 | 69842-814-77 | CVS Health Lidocaine Cream | CREAM | 2019-09-03 | M017 |
| 15 | 51316-144-01 | CVS Itch relief moisturizing | LOTION | 2023-10-17 | M017 |
| 16 | 69842-301-60 | CVS Arthritis Pain Relief | CREAM | 2016-05-30 | M017 |
| 17 | 51316-165-28 | CVS Health Maximum Strength Hydrocortisone | OINTMENT | 2024-06-01 | M017 |
| 18 | 51316-719-01 | CVS Health MAXIMUM STRENGTH Dandruff Medicated Anti-Seborrheic Dermatitis, anti-dandruff | SHAMPOO | 2024-08-28 | M032 |
| 19 | 51316-387-01 | CVS Health MAXIMUM STRENGTH Dandruff Anti-Seborrheic Dermatitis, anti-dandruff | SHAMPOO | 2024-08-28 | M032 |
| 20 | 51316-178-01 | CVS Daily Dandruff Anti-dandruff | SHAMPOO | 2024-09-04 | M032 |
| 21 | 51316-443-01 | CVS Health MAXIMUM STRENGTH Therapeutic Dandruff Anti-dandruff, anti-seborrheic dermatitis, anti-psoriasis | SHAMPOO | 2024-08-28 | M032 |
标准化流程确保专论判定准确、文件齐备、标签合规,缩短整体办理周期。
提交配方表、活性成分、宣称用途及现有检测报告,进行初步合规评估。
比对21 CFR对应专论条款,确认产品归属类别及GRASE活性成分浓度范围。
指定美国代理人,完成FDA药品生产设施注册与产品列名申请。
按21 CFR 201.66制作Drug Facts标签,核对警示语、适应症与使用方法。
提供完整合规文件包,协助清关申报与上市后持续合规维护。
关于 OTC 化妆品出口美国合规的常见疑问解答。
微信号:KOL123567
添加时请备注「公司-职务-姓名」
优先安排资深法规专家 1 对 1 对接
我们已收到您的合规咨询需求
资深 FDA 法规顾问将在 1 个工作日内与您联系